Lv2
166 积分 2023-11-21 加入
B cell biomarkers of rituximab responses in systemic lupus erythematosus
1个月前
已完结
Eythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial
2个月前
已完结
Treatment of Primary Sjögren Syndrome With Rituximab
2个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
2个月前
已完结
Antiemetic doses of dexamethasone and their effects on immune cell populations and plasma mediators of inflammation resolution in healthy volunteers
2个月前
已完结
Macrophages: Targets for next-generation cancer immunotherapy
2个月前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
2个月前
已完结
Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer
5个月前
已完结
1337 The preclinical characterization and translational research of ATG-031, a first-in-class humanized anti-CD24 antibody, for the treatment of solid tumors and hematological malignancies
5个月前
已完结
503 KH-801, a differentated humanized anti-CD24 antibody, potentiates the effects of immunomodulatory and anti-tumor activity in preclinical cancer models with favorable safety profiles
5个月前
已完结
皖公网安备34019202002308
